Article Details

Needham & Company LLC Raises Revance Therapeutics (NASDAQ:RVNC) Price Target to $45.00

Retrieved on: 2021-01-08 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Needham & Company LLC Raises Revance Therapeutics (NASDAQ:RVNC) Price Target to $45.00. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-rvnc-a-buy-or-sell-right-now-2021-01/

Excerpt

Vanguard Group Inc. now owns 2,894,383 shares of the biopharmaceutical company's stock worth $70,681,000 after buying an additional 224,934 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up